New vistas in anti-inflammatory therapy

Nephron

Volumn 88, Issue 4, 2001, Pages 289-295

  Wardle, Nigel ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ARACHIDONIC ACID; CYTOCHROME P450; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPOXYICOSATRIENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LIPOXIN; LIPOXIN A; LIPOXIN B; LIPOXYGENASE; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BLOOD VESSEL PERMEABILITY; GLOMERULONEPHRITIS; HUMAN; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; TH1 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INTERLEUKINS; LEUKOTRIENES; LIPOXINS; NF-KAPPA B;

EID: 0034944543     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046011     Document Type: Review

References (72)

1. Arachidonate cyclo-oxygenase and lipoxygenase products in the mediation of glomerular immune injury
2. Hemodynamic role of arachidonate 12- and 5-lipoxygenases in nephrotoxic serum nephritis
3. Leukotrienes and lipoxins: Lipoxygenase derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis
4. Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis
5. Lipoxin A4 antagonises cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells
6. 15-Lipoxygenase products as leukotriene antagonists: Therapeutic potential in glomerulonephritis
7. Selective inhibition of 5-lipoxygenase attenuates glomerulonephritis in the rat
8. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors
9. Pathogen induced chemokine secretion from intestinal epithelium is inhibited by lipoxin A4 analogs
10. Lipoxins stimulate macrophages to phagocytose apoptotic neutrophils
11. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: Selective inactivation by dehydrogenation and reduction
12. Apoptosis in disease
13. Induction of apoptosis and glomerular disease
14. Sensitivity of 5-lipoxygenase to inhibitors and activating lipid hydroperoxides
15. Glutathione regulation of neutral sphingomyelinase in TNF-α-induced cell death
16. The change in leukotrienes and lipoxins in activated mouse peritoneal macrophages
17. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators
18. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
19. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis
20. Switching off renal inflammation by anti-inflammatory mediators
21. Localisation and abundance of 5 lipoxygenase, 15 lipoxygenase, 12 lipoxygenase and leukotriene A4 hydrolase gene expression in cultured glomerular cells
22. Interleukin-4 ameliorates experimental glomerulonephritis and upregulates glomerular gene expression of IL-1 decoy receptor
23. Immune modulation with interleukin 4 and interleukin 10 prevents crescent formation and glomerular injury in experimental glomerulonephritis
24. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B cell function
25. In vivo suppression of NFκB and preservation of IκB by IL-10 and IL-13
26. Interleukin 10 inhibits nuclear factor κB activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
27. Regulation of neutrophil chemokines by IL-10 expression
28. Interleukin 10, a novel cytotoxic T cell differentiation factor
29. Function and activation of NFκB in the immune system
30. Nuclear factor-κB - A pivotal transcription factor for chronic inflammatory diseases
31. Phosphorylation meets ubiquitination: The control of NF-κB activity
32. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules
33. Antioxidant and redox regulation of gene transcription
34. Crucial role of the amino-terminal tyrosine residue 42 and carboxyl terminal PEST domain of IκBαin NF-κB activation by oxidative stress
35. IκB kinase-β: NFκB activation and complex formation with IκB kinase-α and NIK
36. The IKK complex: An integrator of all signals that activate NF-κB
37. Adoptive transfer of NFκB inactive macrophages to the glomerulus
38. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes
39. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
40. 2 receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endo-thelial cells
41. NFκB is activated during inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression
42. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
43. Inducible cyclooxygenase may have anti-inflammatory properties
44. Anti-inflammatory effect of heat shock protein induction is related to stabilization of IκB-α through preventing IκB kinase activation in respiratory epithelial cells
45. Anti-inflammatory actions of 15-deoxy-Δ-12,14-prostaglandin J2 and troglitazone: Evidence for heat shock-dependent and independent inhibition of cytokine-induced inducible nitric oxide syn-thase expression
46. Peroxisome proliferator-activated receptors: A family of lipid-activated transcription factors
47. The PRARγ is a negative regulator of macrophage activation
48. PPARγ agonists inhibit production of monocyte inflammatory cytokines
49. Inhibition of iNOS by PPAR agonists: Correlation with induction of heme oxygenase 1
50. 2 potentiated iNOS expression by macrophages requires NFκB activation
51. PPAR-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells
52. Chemokines, chemokine receptors and renal disease
53. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-beta
54. Decreased interleukin 12 production and Th1 cell development by acetylsalicylic acid mediated inhibition of NFκB
55. Sulfasalazine: A potent and specific inhibitor of NFκB
56. Sanguinarine is a potent inhibitor of NFκB activation
57. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients
58. Sulindac inhibits activation of the NFκB pathway
59. Enalapril increases antioxidant enzyme activity in renal cortical tissue of five-sixths-nephrectomised rats
60. Silymarin suppresses TNF induced activation of NFκB, cJun terminal kinase and apoptosis
61. Suppression of TNF-alpha;-mediated NFkB activity by myricetin and other flavonoids through down-regulating the activity of IKK in ECV304 cells
62. Resveratrol suppresses TNF-αinduced activation of nuclear transcription factors NFκB, AP-1 and apoptosis
63. Activation of transcription factor NFκB is suppressed by curcumin
64. Inhibition of Cox-2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NFκB activation by NIK/IKK signalling complex
65. Inhibition of NFκB activation by vitamin E derivatives
66. Correlation between NFκB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma
67. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
68. NF-κB and caspases cooperatively regulate the activation and apoptosis of human macrophages
69. 3: Involvement of NF-κB downregulation in transcriptional repression of the p40 gene
70. Retinoids inhibit interleukin 12 production in macrophages through physical association of retinoid X receptor and NF-κB
71. T suppressor lymphocytes inhibit NF-κB mediated transcription of CD86 in antigen presenting cells
72. NF-κB inhibition ameliorates angiotensin II induced inflammatory damage in rats